Davies, HD, et al.
Invasive group A streptococcal infections in Ontario, Canada. New England Journal of Medicine
1996; 335: 547–554.
Hoge, CW, et al.
The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome: a retrospective population-based study. Journal of the American Medical Association
1993; 269: 384–389.
Lepoutre, A, et al.
Epidemiology of invasive Streptococcus pyogenes infections in France in 2007. Journal of Clinical Microbiology
2011; 49: 4094–4100.
O Grady, K, et al.
The epidemiology of invasive group A streptococcal disease in Victoria, Australia. Medical Journal of Australia
2007; 186: 565–569.
O'Loughlin, RE, et al.
The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000–2004. Clinical Infectious Diseases
2007; 45: 853–862.
Safar, A, et al.
Invasive group A streptococcal infection and vaccine implications, Auckland, New Zealand. Emerging Infectious Diseases
2011; 17: 983–989.
Steer, AC, et al.
Prospective surveillance of invasive group A streptococcal disease, Fiji, 2005–2007. Emerging Infectious Diseases
2009; 15: 216–222.
Carapetis, J, et al.
Clinical and epidemiological features of group A streptococcal bacteraemia in a region with hyperendemic superficial streptococcal infection. Epidemiology and Infection
1999; 122: 59–65.
Gear, R, et al.
Changes in the clinical and epidemiological features of group A streptococcal bacteraemia in Australia's Northern Territory. Tropical Medicine & International Health
2014; 20: 40–47
Norton, R, et al.
Invasive group A streptococcal disease in North Queensland (1996–2001). Indian Journal of Medical Research
2004; 119: 148–151.
Lamagni, T, et al.
Predictors of death after severe streptococcus pyogenes infection. Emerging Infectious Diseases
2009; 15: 1304–1307.
Bailie, RS, et al.
Skin infection, housing and social circumstances in children living in remote Indigenous communities: testing conceptual and methodological approaches. BMC Public Health
2005; 5: 128–139.
Carapetis, JR, Wolff, DR, Currie, BJ. Acute rheumatic fever and rheumatic heart disease in the top end of Australia's Northern Territory. Medical Journal of Australia
1996; 164: 146–149.
Hanna, JN, Heazlewood, RJ. The epidemiology of acute rheumatic fever in Indigenous people in north Queensland. Australian and New Zealand Journal of Public Health
2005; 29: 313–317.
Marshall, CS, et al.
Acute post-streptococcal glomerul phritis in the Northern Territory of Australia: a review of 16 years data and comparison with the literature. American Journal of Tropical Medicine and Hygiene
2011; 85: 703–710.
McMillan, DJ, et al.
Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study. Clinical Microbiology and Infection
2013; 19: E222–E229.
Steer, AC, Dale, JB, Carapetis, JR. Progress toward a global group a streptococcal vaccine. The Pediatric Infectious Disease Journal
2013; 32: 180–182.
Breiman, RF, et al.
Defining the group A streptococcal toxic shock syndrome: rationale and consensus definition. Journal of the American Medical Association
1993; 269: 390–391.
Sanderson-Smith, M, et al.
A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development. Journal of Infectious Diseases
2014; 210: 1325–1338.
Laupland, KB, et al.
Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Pediatrics
2000; 105: e60–e69.
Middleton, B, Morris, P, Carapetis, J. Invasive group A streptococcal infection in the Northern Territory, Australia: Case report and review of the literature. Journal of Paediatrics and Child Health
2014; 50: 869–873.
Currie, BJ, Carapetis, JR. Skin infections and infestations in Aboriginal communities in northern Australia. Australasian Journal of Dermatology
2000; 41: 139–143.
McDonald, MI, et al.
Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic. Clinical Infectious Diseases
2006; 43: 683–689.
Clucas, DB, et al.
Disease burden and health-care clinic attendances for young children in remote Aboriginal communities of northern Australia. Bulletin of the World Health Organization
2008; 86: 275–281.
Bessen, DE, et al.
Contrasting molecular epidemiology of group A streptococci causing tropical and nontropical infections of the skin and throat. Journal of Infectious Diseases
2000; 182: 1109–1116.
Towers, RJ, et al.
Extensive diversity of Streptococcus pyogenes in a remote human population reflects global-scale transmission rather than localised diversification. PLoS ONE
2013; 8: e73851.
Richardson, LJ, et al.
Diversity of emm sequence types in group A beta-haemolytic streptococci in two remote Northern Territory Indigenous communities: Implications for vaccine development. Vaccine
2010; 28: 5301–5305.
Steer, AC, et al.
Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infectious Diseases
2009; 9: 611–616.
Dale, JB, et al.
New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci. Vaccine
2011; 29: 8175–8178.
Australian Institute of Health and Welfare. National drug strategy household survey report. Canberra. 2011, cat. no. PHE 145, 2010.
Moore, M, et al.
Prevention of invasive group A streptococcal disease among household contacts of case patients and among postpartum and postsurgical patients: recommendations from the Centers for Disease Control and Prevention. Clinical Infectious Diseases
2002; 35: 950–959.
Public Health Agency of Canada. Guidelines for the prevention and control of invasive group A streptococcal disease. Canada Communicable Disease Report
2006; 32 (S2): 1–26.
Northern Territory Government: Department of Health. Management of contacts of patients with group A streptococcus, 2014, pp. 1–21.